Cambridge, Massachusetts

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more:

Bristol-Myers Squibb is actively conducting translational medicine research to further our understanding of cancer biology and to identify which patient populations may be more likely to derive benefit from Immuno-Oncology (I-O).  Bristol-Myers Squibb has long believed the future of cancer research is dependent on investments in science and partnerships. Collaboration is integrated into our organizational framework across translational medicine and R&D.

We have an exciting new opportunity for a Solid Tumor Oncology Diagnostic Sciences Director / Senior Director to join the Translational and Diagnostic Sciences Organization, where our vision is for tumor biology to inform treatment selection for each patient at each stage of therapy. BMS is seeking a leader with exceptional scientific, strategic and occupational acumen to lead and develop companion and complementary diagnostics (CDx) biomarkers in support of the BMS portfolio. 

The Director / Senior Director, Solid Tumor Oncology Diagnostic Sciences role is the subject matter expert responsible for the development and execution of the companion/complementary biomarker diagnostic strategy for BMS product development and brand teams.  Working within the Translational Medicine matrix, the Solid Tumor Oncology Diagnostic Sciences Lead provides evaluation, strategy, development and delivery of diagnostic products that enhance value of the pharmaceutical product profile.  BMS is seeking a Director / Senior Director of Solid Tumor Oncology Diagnostic Sciences to fulfill this critical role.


  • Directs Solid Tumor Oncology Diagnostic Sciences on asset Development, Brand, and Translational Medicine teams for which companion, complementary, or other in vitro diagnostic development is within strategy.
  • Responsible for developing the Solid Tumor Oncology Diagnostic Sciences strategy for in vitro diagnostic (IVD) programs for immunohistochemistry, Immunoassay, PCR and NGS (tissue and blood based) including bioinformatics approaches.
  • Leads Solid Tumor Oncology Diagnostic Sciences matrix sub teams to enhance the value of the assets through incorporation of diagnostic biomarkers into exploratory, clinical, regulatory, and Medical/Commercial strategies.
  • Provides strategic direction to business development led search, evaluation and transactions for diagnostic partnering.
  • Coordinates all executable activities between the Development/Brand team and external diagnostic partners. Responsible for delivery of diagnostic partner critical milestones, e.g. technical development and validation, clinical validation, and regulatory activities.
  • Participates in commercial planning and medical strategy as related to the diagnostic product.
  • Provides internal and external subject matter expertise for BMS Solid Tumor Oncology Diagnostic Sciences and precision medicine activities: 
  • Acquires and disseminates precision medicine knowledge for organizational learning and capability;
  • Represents BMS Solid Tumor Oncology Diagnostic Sciences to external stakeholders including health authorities, medical customers and presentations at scientific meetings.

BASIC ESSENTIAL CRITERIA/QUALIFICATION: Advanced technical degree, e.g., PhD, MD, DVM, PharmD.  Specific experience in the diagnostic and pharmaceutical industries, oncology biomarkers, diagnostic business development, and/or certification in laboratory medicine (e.g. ASCP) is a plus. Minimum of 5-7 years’ experience in assay and IVD development including analytical validation, clinical development, manufacturing, US and global regulatory submission, and commercialization of diagnostics. Experience with or good working knowledge of a broad range of biomarker/in vitro diagnostic platforms. Demonstrated matrix leadership skills and the ability to work effectively in a matrix team across multiple disciplines internal and external to the organization.

If you come across a role that intrigues you but doesn’t perfectly line up with your resume, we encourage you to apply anyway. You could be one step away from work that will transform your life and career.

Uniquely Interesting Work, Life-changing Careers
With a single vision as inspiring as “Transforming patients’ lives through science™ ”, every BMS employee plays an integral role in work that goes far beyond ordinary. Each of us is empowered to apply our individual talents and unique perspectives in an inclusive culture, promoting diversity in clinical trials, while our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

On-site Protocol
Physical presence at the BMS worksite or physical presence in the field is a necessary job function of this role, which the Company deems critical to collaboration, innovation, productivity, employee well-being and engagement, and it enhances the Company culture.

COVID-19 Information
To protect the safety of our workforce, customers, patients and communities, the policy of the Company requires all employees and workers in the U.S. and Puerto Rico to be fully vaccinated against COVID-19, unless they have received an exception based on an approved request for a medical or religious reasonable accommodation. Therefore, all BMS applicants seeking a role located in the U.S. and Puerto Rico must confirm that they have already received or are willing to receive the full COVID-19 vaccination by their start date as a qualification of the role and condition of employment. This requirement is subject to state and local law restrictions and may not be applicable to employees working in certain jurisdictions such as Montana. This requirement is also subject to discussions with collective bargaining representatives in the U.S.

BMS is dedicated to ensuring that people with disabilities can perform complex functions through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or in any part of the recruitment process, direct your inquiries to Visit to access our complete Equal Employment Opportunity statement.

BMS will consider for employment qualified applicants with arrest and conviction records, pursuant to applicable laws in your area.

Any data processed in connection with role applications will be treated in accordance with applicable data privacy policies and regulations.

Cambridge, Massachusetts

Bristol-Myers Squibb is a global BioPharma company firmly focused on its Mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.

At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers’ needs, giving maximum priority to accelerating pipeline development, delivering sales growth and continuing to manage costs.

The strategy is working. For the past three years, our total return for shareholders, including dividends, has been among the best in the industry. We outperformed most mega pharma companies, diversified companies and pure biotech companies. Reflecting our long-standing commitment to deliver shareholder value, our company has paid dividends to stockholders for more than 300 consecutive quarters.

In addition, we have delivered 13 new medicines to patients since 2002, and we have the possibility of two new approvals in 2012.

Our R&D organization is considered among the most productive in the industry. And the String of Pearls strategy of innovative alliances, partnerships and acquisitions further enhances our internal capabilities. Our full array of pearls encompasses many of our key disease areas, including cancer, cardiovascular disease, immunology, neuroscience and virology.

Pursuing our Mission also means we are working to provide patient access to health care. We are striving to that goal through public/private partnerships like SECURE THE FUTURE, our groundbreaking $150 million program to help confront HIV/AIDS in Africa. In addition, through our patient assistance programs, we provide free medications to qualifying patients with financial hardship in the U.S.

Innovation is critical for successfully executing our BioPharma strategy. That innovation is enhanced by a diverse workforce and an inclusive culture. Bristol-Myers Squibb has been recognized year after year as one of the best companies for female executives and working mothers. We’ve also been recognized by the Human Rights Campaign Foundation’s Corporate Equality Index for achieving a perfect score for four consecutive years.

Preservation of our natural resources also represents one of our key commitments. At many of our facilities worldwide, our company is integrating comprehensive energy management, pollution controls and other practices to reduce environmental impacts. Bristol-Myers Squibb is recognized among the leading sustainability-driven companies.

Bristol-Myers Squibb delivers on its commitments: to our patients and customers, to our employees, to our global communities, to our shareholders and to our environment.

Ultimately, our success as a BioPharma leader is measured by the difference we make in the lives of patients. I invite you to listen to some of those stories – which may also be those of our own employees – throughout our website and on

Similar jobs